Kamal Abu Eita

Kamal Abu Eita

Ask VT AI
View News Summary
  • Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
  • European stocks rise on US-China tariff truce and Ukraine tensions, with focus on upcoming inflation data and Trump-Putin summit.
  • Illegal immigrant sentenced to life for brutal murder of Maryland jogger
5 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Ask VT AI
View News Summary
  • Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
  • European stocks rise on US-China tariff truce and Ukraine tensions, with focus on upcoming inflation data and Trump-Putin summit.
  • Illegal immigrant sentenced to life for brutal murder of Maryland jogger
5 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Kamal Abu Eita